Hundreds of substances, organisms, and physical exposures have been formally classified as cancer-causing agents, spanning everything from tobacco smoke and ultraviolet light to certain infections and even some chemotherapy drugs. The International Agency for Research on Cancer (IARC), part of the World Health Organization, maintains the most widely referenced classification system, sorting agents into groups based on the strength of evidence linking them to human cancer. Group 1, designated “carcinogenic to humans,” currently lists over 120 agents. But the label “carcinogen” covers an enormous range of mechanisms and magnitudes of risk, and understanding what is actually on that list, and how each agent does its damage, matters more than simply knowing a name.
Tobacco Smoke and Its Chemical Payload
Tobacco smoke is the single most preventable cause of cancer worldwide, and it earns that distinction partly because it is not one carcinogen but a complex mixture of them. Two important classes stand out: polycyclic aromatic hydrocarbons (PAHs) and nicotine-derived nitrosamines, particularly a compound called NNK. These chemicals do not cause cancer directly in the form you inhale them. The body’s own metabolism converts them into reactive forms that latch onto DNA, creating what researchers call “bulky DNA adducts,” essentially chemical damage stitched into the genetic code.1PubMed Central. Formation and repair of tobacco carcinogen-derived bulky DNA adducts If the cell’s repair machinery fails to fix these adducts before the DNA is copied, the result is a permanent mutation.
The specificity of this damage is striking. Research has shown that PAH-derived adducts preferentially form at the same spots on the p53 gene where mutations cluster in lung tumors, producing a characteristic pattern of G-to-T transversion mutations that accounts for more than half of such mutations in lung cancers.2Oncogene. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Meanwhile, NNK and its relative NNN cause mutations in both cancer-promoting genes and tumor-suppressor genes, effectively hitting the accelerator and cutting the brakes at the same time.3PubMed Central. Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN This multi-pronged genetic attack is a big reason tobacco smoke is linked to cancers in so many different organs, not just the lungs.
Workplace and Industrial Chemicals
Some of the earliest recognized carcinogens were occupational. Observations of unusual cancer rates in certain trades go back centuries, and the pattern has continued with modern industrial chemistry. Two workplace exposures remain especially consequential: benzene and asbestos.
Benzene, a solvent still widely used in industry, is a well-established cause of leukemia and related blood cancers. It targets the stem and progenitor cells from which all blood cells originate.4PubMed Central. Benzene, the exposome and future investigations of leukemia etiology The body breaks benzene down into several metabolites, and those metabolites interfere with the normal behavior of blood-forming cells in multiple ways at once: damaging DNA, disrupting cell signaling, and pushing precancerous cells toward uncontrolled self-renewal.5Toxicology. Benzene-induced hematotoxicity enhances the self-renewal ability of HSPCs in Mll-Af9 mice This multi-hit mechanism is part of why benzene exposure can be dangerous even at relatively low levels over long periods.
Asbestos operates through an entirely different process. When inhaled, the tiny mineral fibers lodge in the lining of the lungs or abdomen and stay there permanently. Immune cells try to engulf and destroy the fibers but cannot, a process called frustrated phagocytosis.6PubMed Central. Recent progress and perspectives on the mechanisms underlying Asbestos toxicity The result is decades of chronic inflammation, during which cells release reactive oxygen species that continually damage the DNA of nearby tissue. Over time, this inflammatory microenvironment drives the cells lining the lungs or chest cavity toward cancerous transformation, often producing mesothelioma.7PubMed Central. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review The latency period can be extraordinarily long, often 20 to 50 years between first exposure and diagnosis, which is why mesothelioma cases continue to appear today from exposures that occurred in the mid-20th century.8PubMed Central. How asbestos and other fibers cause mesothelioma
Radiation as a Carcinogen
Radiation-related carcinogens fall into two broad camps: ultraviolet light from the sun and ionizing radiation from sources like radon gas, medical imaging, and nuclear events. Both damage DNA, but they do it differently.
Ultraviolet radiation, particularly UVB, is the primary environmental cause of skin cancer. It works by fusing adjacent DNA bases together into structures called cyclobutane pyrimidine dimers, which distort the DNA helix and lead to mutations if not repaired before the cell divides.9PubMed Central. Mechanisms of UV-induced mutations and skin cancer Interestingly, even UVA, the longer-wavelength radiation that penetrates deeper into the skin and dominates tanning-bed output, produces these same DNA lesions, though through a different chemical pathway.10PubMed Central. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation That finding undermined the older notion that UVA was the “safe” part of the spectrum.
Radon, a colorless and odorless radioactive gas that seeps up from certain types of rock and soil, is the second leading cause of lung cancer after smoking and the leading cause among people who have never smoked.11PubMed Central. Radon and Lung Cancer: Current Trends and Future Perspectives Radon and its decay products emit alpha particles, a form of ionizing radiation that is extremely damaging to cells at close range. Because radon tends to accumulate indoors, particularly in basements and ground-floor rooms, residential exposure is a widespread and largely invisible risk. Testing is inexpensive and widely available, yet most homes have never been checked.
Infections That Cause Cancer
Roughly one in six cancers globally is linked to an infectious agent. This fact surprises many people, because cancer is not typically thought of as something you can “catch.” You cannot catch the cancer itself, but certain viruses and bacteria create the conditions for it over many years.
Human papillomavirus (HPV) is the most prominent example. High-risk strains of HPV produce two proteins, E6 and E7, that bind to and disable the cell’s key tumor-suppressor proteins, p53 and Rb1. With those brakes removed, infected cells lose control of DNA replication, DNA repair, and programmed cell death.12PubMed. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle This is why persistent HPV infection is responsible for nearly all cervical cancers and a growing share of cancers of the throat, anus, and genitals. The existence of effective HPV vaccines makes this one of the few cancers where a direct prevention tool exists.
Helicobacter pylori, the bacterium best known for causing stomach ulcers, is the dominant risk factor for gastric adenocarcinoma. Strains carrying the CagA protein are the most dangerous. CagA is now recognized as the first bacterial oncoprotein directly linked to human cancer: it hijacks signaling pathways inside stomach cells, promoting uncontrolled growth and interfering with the BRCA1 tumor suppressor in ways that destabilize the genome over time.13PubMed. Impact of the Helicobacter pylori Oncoprotein CagA in Gastric Carcinogenesis Because infection typically starts in childhood but cancer develops decades later, the process appears to follow a “hit-and-run” pattern: even after the bacteria are eradicated, the accumulated genomic damage can be enough to sustain cancer progression.14PubMed. Helicobacter pylori CagA protein induces gastric cancer stem cell-like properties through the Akt/FOXO3a axis Recent research has also found that CagA helps tumors evade the immune system by stabilizing PD-L1, a protein that shields cancer cells from T cell attack.15Cell Death & Disease. Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE
Hepatitis B virus (HBV) causes liver cancer through yet another mechanism. HBV can insert fragments of its own genetic material into the human genome, disrupting the host’s genomic stability and potentially knocking out genes that normally restrain cell growth.16Cancer Letters. Hepatitis B virus-induced hepatocellular carcinoma Chronic HBV infection also maintains ongoing liver inflammation, which further drives the accumulation of mutations over the years. The cancer risk climbs even higher in regions where HBV-infected individuals are also exposed to aflatoxin B1, a mold-produced toxin found in contaminated grain and peanuts. A meta-analysis of dozens of studies found that the frequency of a particular p53 mutation in liver tumors was strongly correlated with the level of aflatoxin exposure in the local population.17AACR Journals. Hepatitis B, Aflatoxin B1, and p53 Codon 249 Mutation in Hepatocellular Carcinomas from Guangxi, People’s Republic of China, and a Meta-analysis of Existing Studies
Diet, Cooking Methods, and Alcohol
Dietary carcinogens are among the most debated. The evidence is clearest for two: aflatoxin (discussed above in the context of liver cancer) and acetaldehyde, the first breakdown product of alcohol. Beyond those, the picture gets murkier.
Alcohol consumption is a strong and well-established risk factor for cancers of the throat, esophagus, liver, colon, and breast. The main culprit appears to be acetaldehyde, which is toxic, causes mutations in animal experiments, and binds directly to DNA to form the same kinds of adducts seen with other chemical carcinogens.18PubMed Central. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism People who carry certain gene variants affecting how quickly they produce or clear acetaldehyde face markedly different risks. Variants of the ADH1B, ADH1C, and ALDH2 genes, which are common in East Asian populations, influence esophageal cancer risk by altering how long acetaldehyde lingers in the body.19Carcinogenesis. Alcohol metabolism and oesophageal cancer: a systematic review of the evidence
Meat and cooking methods present a more complicated story. Cooking any meat at very high temperatures, grilling over open flame, deep-frying, or pan-searing until charred, produces heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons. Processed meats also contain N-nitroso compounds. All three classes are carcinogenic in animal models. A large study of screening-detected colorectal adenomas found that red meat and meat cooked at high temperatures were associated with a modest increase in the risk of precancerous polyps.20PubMed. Meat, meat cooking methods and preservation, and risk for colorectal adenoma Multiple epidemiological reviews have concluded that high intake of well-done meat and high HCA exposure are associated with increased cancer risk overall.21PubMed Central. Well-done meat intake, heterocyclic amine exposure, and cancer risk However, not every large study agrees. The Multiethnic Cohort Study, one of the largest prospective investigations, found no clear association between total meat, red meat, or processed meat intake and colorectal cancer risk in its models.22PubMed Central. Meat Consumption, Heterocyclic Amines, and Colorectal Cancer Risk: The Multiethnic Cohort Study The authors did not rule out the possibility of a modest effect, but the signal was far weaker than the confident headlines about red meat often suggest. In practical terms, the risk from occasional grilled steak is probably very small; the concern is with consistently high intake and consistently high-temperature cooking over many years.
Hormones and Medical Treatments
Some carcinogens come from inside the body itself, or from therapies meant to treat disease. Estrogen is the most studied hormonal carcinogen. In breast tissue that expresses the estrogen receptor alpha (ERα), estrogen promotes cell division and drives tumor growth. Laboratory research has shown that estrogen and progesterone together push breast cancer cells into active phases of the cell cycle more aggressively than either hormone alone.23PubMed Central. Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression This is why prolonged estrogen exposure, whether from early puberty, late menopause, hormone replacement therapy, or obesity (fat tissue produces estrogen), is a recognized breast cancer risk factor. The picture is not entirely one-directional, though. A second type of estrogen receptor, ERβ, appears to have the opposite effect, inhibiting proliferation and even preventing tumor formation in cell models.24Cancer Research. Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest The balance between these two receptors in a given tissue helps determine whether estrogen fuels or restrains cancer growth.
Certain cancer treatments are themselves carcinogens. Alkylating agents, a class of chemotherapy drugs that work by directly cross-linking DNA to kill rapidly dividing cancer cells, can also damage the DNA of healthy cells and raise the risk of developing a second, different cancer years later. Topoisomerase inhibitors and anthracycline drugs carry similar risks.25PubMed. Chemotherapy-induced secondary malignancies A causal link between alkylating agents and treatment-related leukemia has been firmly established, as has the connection between cyclophosphamide and bladder cancer.26Acta Oncologica. Secondary malignancies following cancer chemotherapy Oncologists weigh this risk against the benefit of treating the existing cancer, but it underscores an uncomfortable truth: the most powerful tools against cancer sometimes plant the seeds for a future one.
How Dose and Mechanism Shape Risk
Not all carcinogens follow the same dose-risk relationship, and the difference matters for regulation and for personal decisions. The field draws a fundamental distinction between agents that damage DNA directly (genotoxic carcinogens) and agents that promote cancer through other pathways (non-genotoxic carcinogens).
Genotoxic carcinogens, including tobacco-smoke chemicals, benzene metabolites, and aflatoxin, interact directly with DNA. Because even a small number of DNA lesions can in principle lead to a mutation that initiates a tumor, regulators generally treat these agents as having no safe threshold: any exposure carries some theoretical risk, however tiny.27PubMed Central. Mode of action-based risk assessment of genotoxic carcinogens Non-genotoxic carcinogens, by contrast, promote cancer through mechanisms such as chronic inflammation, hormonal stimulation, immune suppression, or sustained cell damage that forces tissue to regenerate repeatedly. Examples include dioxin (which acts through a receptor), cyclosporine (which suppresses immune surveillance), and estrogen (which drives cell proliferation).28Mutation Research/Reviews in Mutation Research. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach Because these mechanisms generally require a sustained level of exposure to overwhelm the body’s defenses, non-genotoxic carcinogens are thought to have a threshold below which risk is negligible.29PubMed Central. Thresholds of Genotoxic and Non-Genotoxic Carcinogens
This distinction shapes how regulations are written. For genotoxic carcinogens, regulators typically set exposure limits as low as technically feasible rather than trying to find a “safe” level. For non-genotoxic ones, regulators may set an acceptable daily intake, the way they do for food additives or contaminants. It is worth knowing that many carcinogens act through both pathways at once: asbestos damages DNA directly while also triggering chronic inflammation, and alcohol’s acetaldehyde forms DNA adducts while the broader metabolic effects of heavy drinking promote tissue damage and regeneration.
Why the Same Exposure Hits People Differently
Two people can smoke the same number of cigarettes for the same number of years, and one develops lung cancer while the other does not. A big part of this variability comes down to inherited differences in the enzymes that process carcinogens. The body handles foreign chemicals in two stages. Phase I enzymes activate the chemicals, often inadvertently converting them into more reactive and dangerous forms. Phase II enzymes then detoxify those reactive forms and shuttle them out of the body. Your personal blend of gene variants in these enzyme families tilts the balance.
Research on lung cancer has found that people with gene variants that ramp up Phase I activation while simultaneously reducing or eliminating Phase II detoxification face a greater overall risk.30PubMed Central. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility In colorectal cancer, association studies have examined polymorphisms across a wide array of these metabolic genes, confirming that the disease is a multifactorial interaction between exposures and the individual genetic background.31Pharmacogenetics and Genomics. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer Even within the glutathione S-transferase family, a major group of detoxification enzymes, certain people carry deletions that eliminate enzyme function altogether, leaving them more vulnerable to the same carcinogen exposure that their neighbor handles with ease.32PubMed Central. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer
This genetic variability is not something most people can act on directly today, at least not in a clinical setting. But it explains why blanket statements like “X causes cancer” are always statistical: they describe what happens across populations, not what will happen to you specifically. It also reinforces a practical point: reducing exposure to known carcinogens is the single most effective strategy precisely because you generally do not know whether your personal enzyme profile makes you more or less susceptible.
Epigenetic Disruption and Non-Genotoxic Pathways
One area of growing research interest is how carcinogens can push cells toward cancer without leaving a fingerprint on the DNA sequence at all. Epigenetic mechanisms, the chemical tags and structural modifications that tell a cell which genes to turn on or off, can be disrupted by both genotoxic and non-genotoxic carcinogens. Changes in DNA methylation patterns and histone modifications have been found in cancers regardless of whether the original carcinogenic trigger damaged DNA directly.33PubMed Central. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications
Recent work has started to uncover specific molecular chains involved. For example, certain tumor-promoting chemicals have been shown to trigger cancerous transformation in cells by silencing a small regulatory RNA molecule called let-7, which normally keeps cancer-promoting genes in check. When let-7 is lost, genes associated with aggressive cell growth get switched on.34Environmental Epigenetics. Non-genotoxic carcinogens (TPA and mezerein) activate tumourous transformation through miR let-7-mediated Hmga2 expression in Bhas42 cells These findings matter because they expand the definition of what counts as a meaningful carcinogenic mechanism. A substance that never directly mutates your DNA can still reprogram your cells’ gene-expression landscape in ways that eventually lead to a tumor. This is part of why carcinogen classification can be contentious: traditional screening tests that look only for DNA damage may miss agents that operate through epigenetic disruption.
From Chimney Sweeps to Modern Classification
The formal study of carcinogens has a surprisingly long history. Eighteenth-century observations that chimney sweeps developed scrotal cancer at unusually high rates provided some of the earliest evidence that environmental agents could cause cancer. Experiments with coal tar on animal skin in the early 20th century confirmed the principle, and subsequent work on radiation, fly genetics, and the structure of DNA eventually unified the field around the idea that carcinogens act primarily by inducing mutations.35PubMed Central. A History of Cancer Research: Carcinogens and Mutagens Today that picture has expanded to include epigenetic disruption and chronic inflammation as recognized cancer-promoting mechanisms, but the core logic remains: identify the agent, characterize how it transforms normal cells, and determine who is most exposed. The list of known carcinogens keeps growing not because the world is getting more dangerous, but because the tools for detection and the studies linking exposures to outcomes keep getting better.